Enantioselective Thiourea-Catalyzed Syntheses of beta-Lactones and beta-Lactams
Enantioselective Thiourea-Catalyzed Syntheses of beta-Lactones and beta-Lactams
批准号:
8122804
负责人:
Pamela Michele Tadross
金额:
$4.63万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-12-01 至 2014-11-30
关键词:
AddressAldehydesAmino AcidsBiological FactorsCapromycinCarbonCephalexinClinicalCommunicable DiseasesCyclizationDevelopmentDiseaseGoalsIminesInfectionKetonesLactamsLactonesLeadMediatingMethodologyMethodsOrganic ChemistryPenicillinsPharmaceutical PreparationsPharmacologic SubstancePhasePreparationProcessReactionResearchSchering-Plough brand of ezetimibeStructureThioureaUbenimexUrsidae FamilyXenicalbeta-Lactamscancer therapycatalystcycloadditiondesignenolate
中文摘要
描述(由申请人提供):内酯和-内酰胺是对治疗疾病和感染至关重要的结构基序,其活性与它们中存在的高度紧张的4元环直接相关。除了临床应用之外,这些化合物是制备其他重要医学结构(如-氨基酸)的有价值的起始材料。尽管它们很重要,高取代-内酯和-内酰胺的催化对映选择性构建方法在底物范围、催化剂设计和通用性方面受到限制。为了解决这些限制,目前的建议提供了一种催化对映选择性方法,使用双功能磷硫脲催化剂,从简单的、非手性的、容易获得的起始材料,一步制备-内酯和-内酰胺。具体来说,硫脲催化剂将介导烯酮与醛、酮和亚胺之间的形式[2+2]环加成反应。通过这一过程,可以产生多种具有邻立体碳的产品。此外,磷硫脲催化剂的应用将允许两个反应伙伴的协同活化,在两个大致相同复杂性的化合物之间形成新的C-C和c -杂原子键,以最大程度的收敛方式。将这种方法产生的-内酯和-内酰胺产品应用于天然产物的全合成和具有重要医学意义的衍生物的制备,将为开发用于治疗癌症和传染病的新型药物制剂提供重要的先导化合物。
英文摘要
DESCRIPTION (provided by applicant): Lactones and -lactams are structural motifs critical to the treatment of disease and infection whose activity is directly related to the highly strained 4-membered ring present in each. Beyond their applications in clinical settings, these compounds are valuable starting materials for the preparation of other medicinally important structures, such as -amino acids. Despite their importance, methods for the catalytic enantioselective construction of highly substituted -lactones and -lactams are limited with regard to substrate scope, catalyst design, and generality. To address these limitations, the current proposal provides a catalytic enantioselective method for the preparation of both -lactones and -lactams in a single step from simple, achiral, and readily available starting materials using a bifunctional phosphinothiourea catalyst. Specifically, the thiourea catalyst will mediate the formal [2+2] cycloaddition reaction between ketenes and aldehydes, ketones, and imines. By this process, a diverse array of products can be generated that bear vicinal stereogenic carbons. Furthermore, the application of a phosphinothiourea catalyst will allow cooperative activation of both reaction partners, forming new C-C and C-heteroatom bonds between two compounds of roughly equal complexity in a maximally convergent fashion. The application of -lactone and -lactam products generated by this method to the total synthesis of natural products and to the preparation of medicinally important derivatives will provide access to important lead compounds for the development of new pharmaceutical agents for the treatment of cancer and infectious disease.
PUBLIC HEALTH RELEVANCE: This proposal outlines a research plan in organic chemistry aimed at the design and development of a new reaction method that will enable the preparation of medicinally important classes of compounds from simple, readily available starting materials. Implementation of this new process will lead to the rapid and efficient synthesis of a wide variety of bioactive structures that are inaccessible by current methodologies. The application of products generated by this method to the total synthesis of naturally occurring molecules and to the preparation of biologically relevant derivatives will provide access to important lead compounds for the development of new pharmaceutical agents for the treatment of cancer and infectious disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Enantioselective Thiourea-Catalyzed Syntheses of beta-Lactones and beta-Lactams
-
批准号:8386192
-
项目类别:
-
资助金额:$4.92万
-
财政年份:2011
-
负责人:Pamela Michele Tadross
-
依托单位:
海外基金